ArticleNature communications2022

Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.

Judit Svensson-Arvelund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.